JPRN-UMIN000024567招募中2 期
Single-dose study to examine the pharmacokinetics of the L-arginine for healthy adults - Single-dose study to examine the pharmacokinetics of the L-arginine for healthy adults
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Subjects who have participated in interventional studies within 16 weeks prior to signing the patient informed consent (2) Subjects who have history disease such as endocrine/metabolic disease, autoimmune disorder and immunodeficiency affects the secondary end point (3) Subjects with serious complications such as heart failure, lung diseases, kidney failure, liver failure and uncontrolled diabetes (4) Subjects with cancer or history of cancer (5) Subjects or breast-feeding women, women suspected of being pregnant and patients who do not consent to prevent conception by taking appropriate means with the assistance of their partners during the study period (6) Subjects considered unsuitable for participation in the study by the principal investigators or sub-investigators
研究者
相似试验
进行中（未招募）
不适用
Study to evaluate a single dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic DisorderThromboembolismMedDRA version: 18.0Level: LLTClassification code 10043566Term: ThromboembolismSystem Organ Class: 100000004866EUCTR2012-001581-15-Outside-EU/EEABristol-Myers Squibb Company44
进行中（未招募）
不适用
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in AdolescentsType 2 Diabetes MellitusEUCTR2014-004993-40-Outside-EU/EEAMerck & Co., Inc.35
进行中（未招募）
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsMedDRA version: 18.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2012-003414-14-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as19
进行中（未招募）
不适用
PK Study in Adolescents with Glucocorticoid-Induced OsteoporosisosteoporosisEUCTR2012-003414-14-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as16
进行中（未招募）
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsOsteoporosisEUCTR2012-003414-14-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.24